Maravai LifeSciences Holdings, Inc.
MRVI
$7.38
$0.081.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -5.03% | -15.35% | -28.34% | -30.47% | -19.95% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -5.03% | -15.35% | -28.34% | -30.47% | -19.95% |
| Cost of Revenue | -12.11% | -5.67% | -0.55% | 2.07% | 2.69% |
| Gross Profit | 11.07% | -31.63% | -67.05% | -68.32% | -46.69% |
| SG&A Expenses | -19.43% | -17.40% | -11.60% | -0.67% | 1.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.07% | -11.83% | -6.45% | 0.30% | 2.18% |
| Operating Income | 38.24% | 2.31% | -71.59% | -184.59% | -129.59% |
| Income Before Tax | 60.44% | 35.29% | 10.14% | -149.47% | -158.25% |
| Income Tax Expenses | 89.32% | -129.81% | -126.45% | -100.55% | -100.50% |
| Earnings from Continuing Operations | 60.12% | 36.41% | 11.12% | 33.91% | -105.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -60.53% | -37.26% | -12.88% | -5.90% | 366.19% |
| Net Income | 59.80% | 35.74% | 9.72% | 46.20% | -43.36% |
| EBIT | 38.24% | 2.31% | -71.59% | -184.59% | -129.59% |
| EBITDA | 68.24% | 6.95% | -201.27% | -13,269.57% | -3,086.03% |
| EPS Basic | 60.65% | 37.13% | 12.21% | 48.97% | -33.27% |
| Normalized Basic EPS | -90.77% | -78.83% | -82.68% | -100.45% | -84.90% |
| EPS Diluted | 60.65% | 37.13% | 12.21% | 48.97% | -33.14% |
| Normalized Diluted EPS | -90.77% | -78.83% | -82.68% | -100.45% | -84.90% |
| Average Basic Shares Outstanding | 2.30% | 3.16% | 4.69% | 5.96% | 7.29% |
| Average Diluted Shares Outstanding | 2.30% | 3.16% | 4.69% | 5.96% | 7.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |